UPDATE : Saturday, November 16, 2019
‘Government is doing best to relieve pain of atopic dermatitis patients’ by Kim Yun-mi 2019-09-05 11:48
Chung-Ang, Hyundae General Hospital to cooperate with Astana Medical University in Kazakhstan by Park Gi-taek 2019-09-04 17:12
Myongji to install 1st multi-person hyperbaric oxygen therapy chamber in Seoul by Lee Han-soo 2019-09-04 17:06
[News analysis] Takeda Korea’s merger with Shire has to surmount big hurdle; labor union by Lee Han-soo 2019-09-04 17:06
JW Pharmaceutical acquires Vietnamese drugmaker by Lee Han-soo 2019-09-04 15:16
Local hospitals develop humanized antibody to treat lupus nephritis by Lee Han-soo 2019-09-04 15:15
Biohealth R&D budget up 16% next year by Kwak Sung-sun 2019-09-04 15:14
'Surgical effect of constrictive pericarditis predictable' by Lee Han-soo 2019-09-03 16:04
Takeda Korea vows to release 16 new drugs by 2023 by Kim Yun-mi 2019-09-03 15:40
Health insurance agency invites officials from African countries by Lee Han-soo 2019-09-03 15:09
SK goes global by developing new drugs, conducting CDMO biz by Jeong Sae-im 2019-09-03 14:58
Multiple myeloma treatment isatuximab named orphan drug by Lee Hye-seon 2019-09-03 11:21
Hanmi, Daewoong among 20 innovative top-tier drugmakers in Asia Pacific by Jeong Sae-im 2019-09-02 17:33
Real-world data of Saxenda disclosed for 1st time in Asia by Kim Yun-mi 2019-09-02 14:39
Antidiabetic Forxiga proves efficacy in heart failure by Kim Yun-mi 2019-09-02 11:35
Daewoong, Medytox differ in interpreting spore appraisal for Nabota by Lee Han-soo 2019-08-30 16:26
Atopic dermatitis patients fall in despair as Dupixent may not get coverage soon by Kim Yun-mi 2019-08-30 16:26
Doctors seem less eager to participate in ‘No-Japan’ campaign. Why? by Lee Han-soo 2019-08-30 15:58
JW Pharmaceutical’s hyperlipidemia drug Livalo safe from diabetes risk by Jeong Sae-im 2019-08-30 14:49
Change in licensing-out contract may be bad sign for Intron Biotechnology by Jeong Sae-im 2019-08-30 14:47
Back to Top